MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MSHL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2012/07/10	03:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/07/06	05:03	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/07/03	04:18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/28	22:00	PR Newswire (US)	Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/06	19:04	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/06	06:28	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/04	22:00	PR Newswire (US)	Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/29	22:00	PR Newswire (US)	Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/26	02:32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	04:27	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/15	23:05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/14	22:00	PR Newswire (US)	Marshall Edwards Completes Rights Offering To Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/08	22:00	PR Newswire (US)	Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/25	22:00	PR Newswire (US)	Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/14	04:59	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/12	03:41	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/10	22:00	PR Newswire (US)	Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/03	22:00	PR Newswire (US)	Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/31	01:34	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/31	01:32	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/28	22:00	PR Newswire (US)	Marshall Edwards CEO to Present at Needham Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	22:00	PR Newswire (US)	Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	19:02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	05:40	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/20	21:55	Edgar (US Regulatory)	Securities Registration Statement (S-1/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/19	22:00	PR Newswire (US)	Marshall Edwards Announces Terms for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/08	02:17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)